CME Group Inc
NASDAQ:CME
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
CME Group Inc
NASDAQ:CME
|
US |
|
C
|
Cardinal Health Inc
F:CLH
|
US |
|
Gap Inc
NYSE:GAP
|
US |
|
Brinks Co
NYSE:BCO
|
US |
|
Pepkor Holdings Ltd
F:S1VA
|
ZA |
|
B
|
Brinks Co
F:PTY
|
US |
|
B
|
Boston Scientific Corp
XBER:BSX
|
US |
|
3
|
3D Systems Corp
BMV:DDD
|
US |
|
CONSOL Energy Inc
NYSE:CNR
|
US |
|
Covivio SA
PAR:COV
|
FR |
Wall St Price Targets
CME Price Targets Summary
CME Group Inc
According to Wall Street analysts, the average 1-year price target for CME is 291.97 USD with a low forecast of 232.3 USD and a high forecast of 346.5 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CME's stock price target?
Price Target
291.97
USD
According to Wall Street analysts, the average 1-year price target for CME is 291.97 USD with a low forecast of 232.3 USD and a high forecast of 346.5 USD.
What is the Revenue forecast for CME Group Inc?
Projected CAGR
-6%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 5 years is -6%.
What is the Operating Income forecast for CME Group Inc?
Projected CAGR
-8%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 5 years is -8%.
What is the Pre-Tax Income forecast for CME Group Inc?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 9%. The projected CAGR for the next 3 years is 7%.
What is the Net Income forecast for CME Group Inc?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 5 years is 7%.
